GATOR1 complex controls cisplatin sensitivity

Zhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya · 2025

Read GATOR1 complex controls cisplatin sensitivity by Zhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12824275.txt.

Description

Cisplatin is a frontline chemotherapy drug, but tumors often learn to resist it. Zhenrui Pan and four co-authors study the GATOR1 complex, a three-protein brake on cell growth signaling, long tied to nutrient sensing. They compare normal airway cells with the complex deleted against lung cancer lines that acquired resistance.

Deleting any GATOR1 member made cells resistant, while restoring it made them sensitive again. Resistant cells pumped the drug out faster, let less in, and so suffered fewer DNA hits, even as their damage response ran hotter. A growth-signaling blocker restored sensitivity alongside the complex. Gene scans of the deleted cells revealed new signatures of the resistance program. The authors argue this second job of GATOR1 should shape anti-resistance strategies. The study appears in 2025.

Catalog record

CREATORZhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12824275

Browse the full library · About the Tower of Babel